PDP Couriers
Provider of temperature-controlled logistics and value-added services for life sciences and healthcare. Offers end-to-end cold chain transport across ambient, refrigerated, frozen and cryogenic ranges, digital monitoring and control-tower oversight, regulatory and customs support for clinical trials and advanced therapies, and specialist services such as direct-to-patient delivery, onboard couriers and lab relocations.
Industries
Nr. of Employees
medium (51-250)
PDP Couriers
Products
Dry ice supply
Supply of dry ice for temperature-controlled shipping and handling.
Liquid nitrogen supply and refilling
Provision and refilling services for liquid nitrogen to support cryogenic transport and storage.
Dry ice supply
Supply of dry ice for temperature-controlled shipping and handling.
Liquid nitrogen supply and refilling
Provision and refilling services for liquid nitrogen to support cryogenic transport and storage.
Services
Integrated logistics services for clinical trials including packaging selection, kit assembly, transport of IMPs and biological samples, stock monitoring and post-trial sample handling.
Specialist logistics for ATMPs including cryogenic transport, chain-of-custody, control tower monitoring and tailored packaging for ultra-low temperature requirements.
Home delivery and pick-up services for trial participants with GDPR measures, SOP-based handling and country-specific customs management.
Dedicated courier physically accompanying high-value or time-critical shipments from pickup to delivery to reduce handling and expedite exception resolution.
Turnkey laboratory relocation services including cryopreservation transfers, LN2 supply, vessel decontamination, tracking and disaster recovery planning.
End-to-end tailored handling for high-value and temperature-sensitive healthcare shipments including expert oversight and continuous tracking.
Integrated logistics services for clinical trials including packaging selection, kit assembly, transport of IMPs and biological samples, stock monitoring and post-trial sample handling.
Specialist logistics for ATMPs including cryogenic transport, chain-of-custody, control tower monitoring and tailored packaging for ultra-low temperature requirements.
Home delivery and pick-up services for trial participants with GDPR measures, SOP-based handling and country-specific customs management.
Dedicated courier physically accompanying high-value or time-critical shipments from pickup to delivery to reduce handling and expedite exception resolution.
Turnkey laboratory relocation services including cryopreservation transfers, LN2 supply, vessel decontamination, tracking and disaster recovery planning.
End-to-end tailored handling for high-value and temperature-sensitive healthcare shipments including expert oversight and continuous tracking.
Expertise Areas
- Temperature-controlled logistics
- Clinical trial logistics and kit management
- Cell and gene therapy logistics (ATMP)
- Direct-to-patient distribution
Key Technologies
- IoT sensor integration for temperature and location
- Blockchain ledger for immutable chain-of-custody
- Real-time monitoring and automated alerting
- Digital study setup and customer portal platforms
News & Updates
Award recognising a digital platform that improves tracking, verification and management of temperature-controlled shipments using IoT sensors and a blockchain ledger.
Press release announcing acquisition by DHL Group to strengthen life-science logistics capabilities.
Acquisition to expand US footprint with operational centres in New York and Los Angeles and to strengthen US capabilities for cell and gene therapy logistics.
Opening of a nationwide cold chain logistics centre to enhance temperature-sensitive shipment capabilities across the US.
Article discussing integration of AI, IoT and blockchain to improve cold-chain visibility and risk management.
Overview of advanced therapy types and the logistics requirements for handling gene, cell and tissue therapies.
Award recognising a digital platform that improves tracking, verification and management of temperature-controlled shipments using IoT sensors and a blockchain ledger.
Press release announcing acquisition by DHL Group to strengthen life-science logistics capabilities.
Acquisition to expand US footprint with operational centres in New York and Los Angeles and to strengthen US capabilities for cell and gene therapy logistics.
Opening of a nationwide cold chain logistics centre to enhance temperature-sensitive shipment capabilities across the US.
Article discussing integration of AI, IoT and blockchain to improve cold-chain visibility and risk management.
Overview of advanced therapy types and the logistics requirements for handling gene, cell and tissue therapies.